Why Teladoc Stock Got Socked for a Loss Thursday

I thought Teladoc stock might be a buy. I was wrong -- and capitalized software costs are the reason why. Teladoc Health (TDOC -5.25%) stock, the telemedicine specialist that made the controversial decision to spend $18.5 billion on diabetes care company Livongo in 2020, reported more bad news last night, sending shares down 8.7% through 10 a.m. ET. Analysts following Teladoc forecast the company would report quarterly losses of $0.35 per share on sales of $649.6 million. As it turned out, the news was even ...